| 000 | 01646 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515055433.0 | ||
| 264 | 0 | _c20070305 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a0586-5964 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDoshi, Ami | |
| 245 | 0 | 0 |
_aThe cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin). _h[electronic resource] |
| 260 |
_bSeton Hall law review _c2007 |
||
| 300 |
_a625-60 p. _bdigital |
||
| 500 | _aPublication Type: Historical Article; Journal Article | ||
| 650 | 0 | 4 |
_aAbnormalities, Drug-Induced _xprevention & control |
| 650 | 0 | 4 |
_aAcne Vulgaris _xdrug therapy |
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xinstrumentation |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xhistory |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFetus |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHistory, 20th Century |
| 650 | 0 | 4 | _aHistory, 21st Century |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsotretinoin _xadministration & dosage |
| 650 | 0 | 4 | _aLegislation, Pharmacy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaternal-Fetal Exchange |
| 650 | 0 | 4 |
_aPharmaceutical Services _xstandards |
| 650 | 0 | 4 |
_aPregnancy _xdrug effects |
| 650 | 0 | 4 | _aReproductive Behavior |
| 650 | 0 | 4 |
_aRisk Management _xmethods |
| 650 | 0 | 4 |
_aSkin Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aSocial Control Policies _xeconomics |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tSeton Hall law review _gvol. 37 _gno. 2 _gp. 625-60 |
|
| 999 |
_c16854297 _d16854297 |
||